|Project name: ||National Proton Beam Therapy (PBT) Service Development Programme - there are 6 reports for this project: 2014, 2015, 2016, 2017, 2018, 2019 |
|Google search: ||Google search on project name (opens in new window) |
|Organisation: ||DOH (D12) - see all reports for this organisation |
|Report year: ||2015 (data is from Sept 2014) |
|Category: ||Infrastructure - see all reports for this category |
|Description: ||To develop a full PBT service in England that delivers the following aims and objectives:-
1) to ensure that all patients, for whom evidence supports PBT as the most clinically effective treatment, receive treatment within a clinically appropriate service specification and to nationally agreed standards.
2) to ensure that services provided enable the continued development of the technologies involved and that workforce and training issues are appropriately addressed.
3) to deliver improved outcomes by ensuring that patients have access to high quality modern radiotherapy techniques comparable to those used in other European countries, to improve patients' experience by minimising any long term side effects of treatment. In particular to :-
a) develop a PBT service that meets the objectives as stated in the SOC December 2011
b) oversee the facilities projects to ensure that the two sites develop a service that meets Commissioner's specifications to time and budget
c) monitor the facilities projects financial governance arrangements to ensure that it delivers value for money
d) manage the transition from an overseas service to a service in England
e) identify and manage the impact of the PBT service on other clinical services
f) develop a national clinical network
g) ensure that a research strategy is in place that informs the future development of the service
h) manage the impact of workforce across radiotherapy services. |
|DCA (RAG): ||Amber |
|DCA text: ||The MPA RAG rating was Amber at Q2 2014.
A detailed Management Action Plan was developed in consultation with the key Programme stakeholders which identified specific actions to be taken to address the findings from the MPA. Due to the complexity and unique nature of the Programme, targeted actions were implemented leading to:
1. Changes in the leadership and governance arrangements for the Programme to enhance the overall robustness by supporting the delivery and effective management of the current phase which largely involves procurement of the equipment, assurance and securing the necessary Government approvals.
2. A revamp of the Programme environment providing clarity to where accountability and responsibilities lies at the various tiers of the National Programme, for example:
A. DH is providing leadership and responsible for:
i. Capital Funding
ii. Programme management and delivery
iii. Approvals and assurance using mandatory Cabinet Office and HM Treasury processes.
B. NHS England is providing leadership and responsible for:
ii. Clinical Services and Referrals
iii. Mobilisation of PBT Services
iv. Clinical Policy development
v. Benefits Management and Realisation
vi. Engagement with key stakeholders including the Devolved Nations and professional organisations
vii. Research and Development.
3. Improvements in the resource levels including confirmation of the core Programme team and use of subject matter experts in specific areas such as the role of a National Clinical Lead for PBT, Workforce Strategy and Development, and Communications.
4. Structured and coordinated stakeholder engagement in particular, the establishment of a National PBT Special Interest Group (SIG) with the active participation of the relevant Clinical Reference Groups (CRGs); Health Education England (HEE); professional organisations such as The Royal College of Radiologists (RCR), The Society and College of Radiographers (SCoR), Institute for Physics and Engineering in Medicine (IPEM). In addition, the Programme also has access to the expertise of specialists in the related fields relevant to developing a national PBT service in England.
Work has been done to develop a national plan for the clinical management of patients who have been clinically assessed to benefit from PBT treatment. Part of this work involves the review and expansion of the clinical indications list via NHS England processes through the development of clinical policies by engaging with the relevant CRGs as a longer term strategy for the viability of a National PBT service. The culmination of these actions has put the Programme on a much improved pedestal in terms of governance, resources, communications, stakeholder engagement and the plans towards the delivery of sustainable benefits. |
|Start date: ||2012-01-01 |
|End date: ||2018-12-31 |
|Schedule text: ||The National PBT Programme remains on schedule to treat first patients in the Spring of 2018. The PBT equipment procurement is at an advanced stage as it is on the critical path of the Programme. In addition, the mandatory assurance and approvals processes have been accelerated by about 6 months - this also provides added assurance to the service commencement date in 2018. |
|Baseline: ||£9.40m |
|Forecast: ||£9.40m |
|Variance: ||0.00% |
|Variance text: ||Budget variance less than 5% |
|Whole Life Cost: ||£1,295.53m |
|WLCost text: ||Estimated Whole Life Costs have not changed significantly. Slight changes arise from a later Service Commencement date assumed in the final Trust OBCs (ramp up commences one Quarter later) and this re-phasing reduces some costs and benefits in the twenty year window of the Project life. |
|Notes1: || DOH NON CAPITAL |
|Notes2: || |
|Sourcefile: ||IPA_2015.csv |
All Projects (+dates)
All Projects (+costs)
Acknowledgement: GMPP data has been re-used under the Open Government Licence.